Daily ReportOct 11, 2026
Sepsis, October 11 edition
We read 33 papers and selected 3.
Summary
Today's most impactful sepsis research spans microcirculatory physiology, outcome-associated immune cell-death programs, and clinically accessible risk stratification. A systematic review found heterogeneous effects of vasopressin analogues on microcirculation, while multi-cohort transcriptomics linked fatal sepsis to relative suppression of pyroptosis and necroptosis programs with enrichment of ferroptosis signatures; a large multicenter analysis identified the blood urea nitrogen-to-albumin ratio as an independently replicated marker of sepsis-associated delirium risk.
Research Themes
- Vasopressor effects on microcirculatory perfusion
- Programmed cell death signatures in fatal sepsis
- Biomarker-based prediction of sepsis-associated delirium
Selected Articles
1. Effect of vasopressin and its analogues on microcirculatory perfusion: a systematic review.
This systematic review included 39 publications comprising 31 animal studies, 7 human studies, and 1 combined study. Across 152 measurements, microcirculatory perfusion decreased in 33%, remained unchanged in 48%, and increased in 19%; effects were heterogeneous in vasodilatory or septic shock, with the renal medulla showing the highest proportion of reduced perfusion.
Impact: The study directly challenges the assumption that improved arterial pressure uniformly translates into improved tissue perfusion. Its vascular-bed-specific synthesis is clinically relevant for balancing vasopressor support against potential regional ischemia.
Clinical Implications: Vasopressin and its analogues should not be judged solely by their ability to increase arterial pressure. In septic shock, clinicians should recognize heterogeneous regional effects and consider monitoring organ perfusion, particularly renal perfusion, when escalating non-adrenergic vasopressors.
Key Findings
- Among 152 measurements, microcirculatory perfusion decreased in 33%, was unchanged in 48%, and increased in 19%.
- In vasodilatory or septic shock, effects were heterogeneous rather than uniformly harmful or beneficial.
- The renal medulla had the highest proportion of measurements showing reduced perfusion, with 77% of reported measurements decreased.
Methodological Strengths
- Systematic searching across MEDLINE, EMBASE, and Web of Science.
- Stratification by haemodynamic condition and vascular bed, integrating animal and human microcirculatory measurements.
Limitations
- The evidence base was dominated by animal studies, with only seven human publications.
- Measurements used heterogeneous comparators, techniques, vascular beds, and clinical conditions, limiting direct quantitative clinical inference.
Future Directions: Prospective human studies should use standardized microcirculatory endpoints and simultaneous organ-function measurements to determine whether regional perfusion changes caused by vasopressin predict acute kidney injury, tissue hypoxia, or clinical outcomes.
OBJECTIVE: Arginine vasopressin (AVP) is a non-adrenergic vasopressor increasingly used in the management of shock. While it restores arterial pressure, its effects on the microcirculation remain uncertain, with potential for reduced regional perfusion and tissue oxygenation. The aim of this systematic review is to evaluate the effects of intravenous AVP and its analogues on microcirculatory perfusion across different haemodynamic conditions and vascular beds. METHODS: A systematic search of MEDLINE, EMBASE, and Web of Science was conducted.
2. Relative suppression of pyroptosis- and necroptosis-related transcriptional programs and enrichment of ferroptosis-related signatures are associated with fatal sepsis: multi-cohort bulk and single-cell transcriptomic evidence.
This integrative analysis of five public sepsis cohorts found that 28-day non-survivors had lower pyroptosis, necroptosis, and apoptosis program scores but higher ferroptosis scores than survivors. Higher pyroptosis scores were associated with better survival, while LPS-stimulated cell experiments confirmed inflammatory responsiveness of selected genes but did not directionally validate the fatal-sepsis signature.
Impact: The study proposes an outcome-linked immune cell-death pattern that differs from a simple model of uniformly excessive inflammatory cell death. Its explicit separation of disease-versus-control contrasts from survivor-versus-nonsurvivor comparisons improves interpretability and identifies testable mechanistic hypotheses.
Clinical Implications: Programmed cell-death transcriptional profiles may eventually support sepsis endotyping and therapeutic selection, but they should not yet guide treatment. The findings reinforce the need for prospective validation before targeting ferroptosis, pyroptosis, or necroptosis in patients.
Key Findings
- In GSE65682, 28-day non-survivors had lower pyroptosis, necroptosis, and apoptosis scores and higher ferroptosis scores than survivors.
- Higher pyroptosis scores were associated with better 28-day survival in the outcome-defined cohort.
- LPS stimulation upregulated CASP1, RIPK3, and NLRP3 and downregulated SIRT1, BCL2, and HIF1A, but these experiments did not functionally validate the fatal-sepsis direction.
Methodological Strengths
- Integration of five independent public cohorts, including both bulk and single-cell transcriptomic datasets.
- Clear distinction between outcome-associated analyses and disease-versus-control exploratory comparisons, with targeted cellular follow-up.
Limitations
- The analyses are largely retrospective and transcriptomic, so they cannot establish causality or functional cell-death activity.
- The LPS experiments were limited to mRNA-level responses and did not reproduce or directionally validate the patient mortality signature.
Future Directions: Prospective, longitudinal studies should define cell-type-specific protein and functional ferroptosis, pyroptosis, and necroptosis markers, integrate them with clinical endotypes, and test whether biomarker-guided modulation improves organ function or survival.
BACKGROUND: Sepsis is a life-threatening syndrome caused by a dysregulated host response to infection and remains a major cause of mortality in critically ill patients. Multiple forms of programmed cell death (PCD) may contribute to immune dysregulation and organ injury, but their transcriptional patterns across disease severity and outcome remain incompletely defined. METHODS: We performed an integrative transcriptomic analysis of five public sepsis cohorts, including single-cell RNA sequencing datasets GSE167363 and GSE151263 and three bulk transcriptomic cohorts.
3. Elevated blood urea nitrogen-to-albumin ratio is associated with incident sepsis-associated delirium: evidence from a weighted competing-risk analysis in a multicenter cohort study.
This multicenter retrospective cohort study analyzed 10,565 patients with sepsis from MIMIC-IV and eICU-CRD. Higher early blood urea nitrogen-to-albumin ratio, particularly the highest quartile, was associated with incident 7-day sepsis-associated delirium after competing-risk adjustment, and the highest-quartile association was independently reproduced in the eICU-CRD cohort.
Impact: The study evaluates a simple, routinely available laboratory ratio against a clinically important neurological complication using a large multicenter dataset and independent replication. Its competing-risk framework is appropriate because death can occur before delirium assessment.
Clinical Implications: Early BAR may help identify septic patients who warrant intensified delirium surveillance and preventive measures. It should be used as a risk-associated marker alongside clinical assessment because the observational design does not establish that modifying BAR reduces delirium.
Key Findings
- The study included 10,565 patients: 9,612 from MIMIC-IV and 953 from eICU-CRD.
- In MIMIC-IV, the highest BAR quartile was associated with higher subdistribution hazard of 7-day delirium than the lowest quartile, with a fully adjusted subdistribution hazard ratio of 1.36 (95% CI 1.13-1.64).
- The association between the highest BAR quartile and delirium was independently reproduced in the eICU-CRD cohort.
Methodological Strengths
- Large multicenter cohort design with an independent external replication cohort.
- Use of competing-risk regression, inverse probability weighting, restricted cubic splines, subgroup analyses, and exploratory machine-learning interpretation.
Limitations
- The retrospective database design leaves potential for residual confounding, measurement bias, and variation in delirium ascertainment.
- BAR is a nonspecific marker influenced by renal function, hydration, nutrition, inflammation, and other acute illness factors; causal or treatment-modifying effects were not demonstrated.
Future Directions: Prospective studies should standardize delirium assessments, evaluate serial BAR trajectories, compare BAR with established delirium prediction models, and test whether BAR-guided prevention or enhanced monitoring improves delirium-related outcomes.
BACKGROUND: Sepsis-associated delirium (SAD) is a frequent manifestation of acute brain dysfunction in sepsis. Although the blood urea nitrogen-to-albumin ratio (BAR) has been associated with prognosis in critically ill patients, its relationship with incident SAD remains uncertain. We evaluated the association between early BAR and incident SAD. METHODS: This multicenter retrospective cohort study included patients with sepsis from MIMIC-IV as the primary cohort and eICU-CRD as an independent replication cohort.